NeoGenomics
NEO
$6.24
Share price
-7.14%
Change (1 day)
-57.00%
Change (1 year)
Revenue for NeoGenomics (NEO)
Revenue in 2025 (TTM): $0.67 Billion USD
According to NeoGenomics
's latest financial reports the company's current revenue (TTM 
) is $0.67 Billion USD. In 2024 the company made a revenue of $0.66 Billion USD an increase over the revenue in the year 2023 that were of $0.59 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for NeoGenomics from 2000 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | $0.67 B | 1.79% |
| 2024 | $0.66 B | 11.65% |
| 2023 | $0.59 B | 16.07% |
| 2022 | $0.50 B | 5.24% |
| 2021 | $0.48 B | 8.97% |
| 2020 | $0.44 B | 8.71% |
| 2019 | $0.40 B | 47.73% |
| 2018 | $0.27 B | 12.21% |
| 2017 | $0.24 B | 1.04% |
| 2016 | $0.24 B | 144.57% |
| 2015 | $99.8 M | 14.62% |
| 2014 | $87.06 M | 30.99% |
| 2013 | $66.46 M | 11.02% |
| 2012 | $59.86 M | 37.68% |
| 2011 | $43.48 M | 26.51% |
| 2010 | $34.37 M | 16.63% |
| 2009 | $29.46 M | 47.23% |
| 2008 | $20.01 M | 73.97% |
| 2007 | $11.5 M | 77.65% |
| 2006 | $6.47 M | 243.5% |
| 2005 | $1.88 M | 237.83% |
| 2004 | $0.55 M | 50.84% |
| 2003 | $0.36 M | |
| 2000 | $0.25 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 RadNet RDNT | $1.86 B | 178.03% | 🇺🇸 USA |
 Psychemedics PMD | $19.68 M | -97.07% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $10.15 B | 1,410.80% | 🇺🇸 USA |
 LabCorp LH | $13.17 B | 1,859.87% | 🇺🇸 USA |
 Enzo Biochem ENZB | $27.47 M | -95.91% | 🇺🇸 USA |